Cargando…
Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?
Autores principales: | Etminan, Mahyar, Sodhi, Mohit, Ganjizadeh-Zavareh, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862017/ https://www.ncbi.nlm.nih.gov/pubmed/33549598 http://dx.doi.org/10.1016/j.chest.2021.01.080 |
Ejemplares similares
-
A comparative safety study of reported neurological adverse events with three COVID-19 vaccines
por: Sodhi, Mohit, et al.
Publicado: (2022) -
Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection
por: Etminan, Mahyar, et al.
Publicado: (2021) -
Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position Statement
por: Gupta, Samir, et al.
Publicado: (2020) -
Fast Development of High-Quality Vaccines in a Pandemic
por: Pischel, Lauren, et al.
Publicado: (2021) -
A practical guide to handling competing events in etiologic time-to-event studies
por: Mansournia, Mohammad Ali, et al.
Publicado: (2022)